Sal Daher, CFA

Talkspace’s COO Mark Hirschhorn is resigning after an internal review of his conduct, the company shared. This comes just a week after the departure of its co-founders and CEO.

The company got a breakthrough device designation for its app-based program for alcohol use disorder, reset-A. Pear currently has FDA-cleared digital therapeutics to address opioid use and substance…

Takeda Pharmaceutical won FDA approval for Livtencity, an antiviral developed to treat cytomegalovirus infection in transplant patients. The agency also approved an Aadi Biosciences drug, making it…

Elizabeth Holmes testified in the Theranos trial that the company’s blood-testing tech ‘performed well’ in early studies with drug makers.

GlaxoSmithKline sees enough promise in the early clinical data of a novel NASH drug to pay its developer, Arrowhead Pharmaceuticals, $120 million up front for rights to the experimental therapy. The…

It is clear that one key to improving the future of the U.S. healthcare system lies in putting the patient at the center of care and aligning around quality.

Califf’s new financial disclosures show he holds between $1 million and $5 million in equity in Google’s life science arm Verily.

Michael Greeley, a venture capitalist, envisions a health care system that will be ‘more responsive, virtual, on-demand, and intelligent.’

For all babies born in 2019 and the five-year period afterward, complications due to pregnancy and childbirth cost at least $32.3 billion.

To train and test AI models thoroughly for use in health care, researchers must have access to representative data.